{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:07:40Z","timestamp":1791900460098,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.cca.2007.02.038","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T12:30:58Z","timestamp":1172665858000},"page":"107-113","source":"Crossref","is-referenced-by-count":157,"title":["Biomarkers of liver fibrosis: Clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests"],"prefix":"10.1016","volume":"381","author":[{"given":"Olav A.","family":"Gressner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel M.","family":"Gressner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2007.02.038_bib1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","article-title":"Evaluation of liver fibrosis: a concise review","volume":"99","author":"Afdhal","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2007.02.038_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cca.2007.02.038_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1053\/j.gastro.2004.02.025","article-title":"A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis","volume":"126","author":"Forbes","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2007.02.038_bib4","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.2741\/887","article-title":"Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell","volume":"8","author":"Gabele","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.cca.2007.02.038_bib5","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.2741\/gressner","article-title":"Roles of TGF-\u03b2 in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.cca.2007.02.038_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(03)00432-X","article-title":"The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply?","volume":"39","author":"Gressner","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2007.02.038_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(94)90133-3","article-title":"Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases","volume":"227","author":"Collazos","year":"1994","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2007.02.038_bib8","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1478-3231.2006.01312.x","article-title":"Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease","volume":"26","author":"Lydatakis","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cca.2007.02.038_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clinchem\/42.4.558","article-title":"Diagnostic accuracy of hyaluronan and type III procollagen amino terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis","volume":"42","author":"Guechot","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.038_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8278(95)80255-X","article-title":"Serum hyaluronan as a marker of liver fibrosis","volume":"22","author":"Gu\u00e9chot","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2007.02.038_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/clinchem\/37.1.30","article-title":"Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum","volume":"37","author":"Kropf","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.038_bib12","first-page":"1369","article-title":"Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1 \u2014 possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis","volume":"49","author":"Flisiak","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cca.2007.02.038_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.510270416","article-title":"(Latent) transforming growth factor-beta in liver parenchymal cells, its injury-dependent release and paracrine effects on hepatic stellate cells","volume":"27","author":"Roth","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2007.02.038_bib14","first-page":"133","article-title":"Connective tissue growth factor is directly related to liver fibrosis","volume":"49","author":"Hayashi","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cca.2007.02.038_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1600-0676.2000.020004296.x","article-title":"Connective tissue growth factor in human liver cirrhosis","volume":"20","author":"Abou-Shady","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.cca.2007.02.038_bib16","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1373\/clinchem.2006.070466","article-title":"Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis","volume":"52","author":"Gressner","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.038_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2007.02.038_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","article-title":"Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2007.02.038_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2007.02.038_bib20","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2007.02.038_bib21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","article-title":"Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection","volume":"51","author":"Adams","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.038_bib22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2005.10.019","article-title":"Performance of serum marker panels for liver fibrosis in chronic hepatitis C","volume":"44","author":"Parkes","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2007.02.038_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.clinbiochem.2004.12.012","article-title":"Analytical variability of the fibrotest proteins","volume":"38","author":"Rosenthal-Allieri","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2007.02.038_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1373\/clinchem.2004.041764","article-title":"Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study","volume":"51","author":"Poon","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.038_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1006","article-title":"Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics","volume":"10","author":"Callewaert","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2007.02.038_bib26","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1007\/BF02087661","article-title":"Alpha-2-macroglobulin and hepatic fibrosis","volume":"V39","author":"Naveau","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2007.02.038_bib27","first-page":"1302","article-title":"Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection","volume":"92","author":"Bonacini","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2007.02.038_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2007.02.038_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1440-1746.2000.02172.x","article-title":"Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?","volume":"15","author":"Park","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2007.02.038_bib30","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0016-5085(91)70030-2","article-title":"A simple biological index for detection of alcoholic liver disease in drinkers","volume":"100","author":"Poynard","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2007.02.038_bib31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0140-6736(93)91946-J","article-title":"Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis","volume":"342","author":"Teare","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2007.02.038_bib32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/clinchem\/47.9.1696","article-title":"Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis","volume":"47","author":"Fortunato","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.02.038_bib33","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/j.1572-0241.2001.05268.x","article-title":"Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection","volume":"96","author":"Pohl","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2007.02.038_bib34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2007.02.038_bib35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2004.08.008","article-title":"Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients","volume":"41","author":"Patel","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2007.02.038_bib36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.20207","article-title":"Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index","volume":"39","author":"Sud","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2007.02.038_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1572-0241.2004.04055.x","article-title":"Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid","volume":"99","author":"Leroy","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cca.2007.02.038_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/hep.20935","article-title":"A novel panel of blood markers to assess the degree of liver fibrosis","volume":"42","author":"Cales","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2007.02.038_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2796.2006.01673.x","article-title":"Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count\/spleen diameter ratio index","volume":"260","author":"Testa","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.cca.2007.02.038_bib40","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T07:47:44Z","timestamp":1587368864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898107001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0009898107001325"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2007.02.038","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}